Kaufman Jonathan H Insider Trades

Insider Trading History

Track insider trading activity for Kaufman Jonathan H. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lipella Pharmaceuticals
Lipella Pharmaceuticals LIPO
10% owner, See Remarks Below.
Holding Value $0 0 shares
Last Trade
Apr 03, 2025 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$1.35M 541,019 shares
$2.50
$0.08
Lipella Pharmaceuticals
Lipella Pharmaceuticals LIPO
10% owner, See Remarks Below.
Holding Value $43k 536,959 shares
Last Trade
Mar 13, 2025 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$31.5k 14,386 shares
$2.19
$0.08
Lipella Pharmaceuticals
Lipella Pharmaceuticals LIPO
10% owner, See Remarks Below.
Holding Value $42.1k 526,633 shares
Last Trade
Mar 10, 2025 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$248k 113,624 shares
$2.18
$0.08
Lipella Pharmaceuticals
Lipella Pharmaceuticals LIPO
10% owner, See Remarks Below.
Holding Value $35.4k 441,933 shares
Last Trade
Feb 28, 2025 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$1.66M 567,766 shares
$2.93
$0.08
Lipella Pharmaceuticals
Lipella Pharmaceuticals LIPO
10% owner, See Remarks Below.
Holding Value $0 0 shares
Last Trade
Jan 15, 2025 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$941k 314,836 shares
$2.99
$0.08
Lipella Pharmaceuticals
Lipella Pharmaceuticals LIPO
10% owner, See Remarks Below.
Holding Value $24.2k 303,041 shares
Last Trade
Dec 31, 2024 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$167k 54,728 shares
$3.05
$0.08
Lipella Pharmaceuticals
Lipella Pharmaceuticals LIPO
10% owner, See Remarks Below.
Holding Value $20.8k 260,108 shares
Last Trade
Dec 23, 2024 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$1.07M 345,529 shares
$3.10
$0.08
Lipella Pharmaceuticals
Lipella Pharmaceuticals LIPO
10% owner, See Remarks Below.
Holding Value $71.9k 898,849 shares
Last Trade
May 14, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$60k 10,000 shares
$6.00
$0.08
Lipella Pharmaceuticals
Lipella Pharmaceuticals LIPO
10% owner, See Remarks Below.
Holding Value $71.1k 888,849 shares
Last Trade
Mar 19, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$149k 25,000 shares
$5.96
$0.08
Lipella Pharmaceuticals
Lipella Pharmaceuticals LIPO
10% owner, See Remarks Below.
Holding Value $69.1k 863,849 shares
Last Trade
Mar 18, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$185k 30,000 shares
$6.16
$0.08
Lipella Pharmaceuticals
Lipella Pharmaceuticals LIPO
10% owner, See Remarks Below.
Holding Value $6.4k 80,000 shares
Last Trade
Mar 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$499k 80,000 shares
$6.24
$0.08
Lipella Pharmaceuticals
Lipella Pharmaceuticals LIPO
10% owner, See Remarks Below.
Holding Value $66.7k 833,849 shares
Last Trade
Mar 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$861k 144,906 shares
$5.94
$0.08
Lipella Pharmaceuticals
Lipella Pharmaceuticals LIPO
10% owner, See Remarks Below.
Holding Value $6.36k 79,500 shares
Last Trade
Jun 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.39M 79,500 shares
$17.52
$0.08
Lipella Pharmaceuticals
Lipella Pharmaceuticals LIPO
See Remarks
Holding Value $0 0 shares
Last Trade
Dec 19, 2022 Sale
$920k 160,000 shares
$5.75
$0.08

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up